Parexel | Sustainability Performance
Manufactures construction materials, including mortars, facades, and adhesives.
1982
United States
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3573
Overallⓘ#722
in United Statesⓘ#87
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionGovernance
Targets
Critical
Controversy level
- Parexel International has faced multiple US FDA Form 483 observations at clinical trial sites including the historic 2018 Massachusetts trial enrollment scandal, plus class actions over inadequate disclosure of pharmaceutical customer pipeline before the 2021 EQT acquisition.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.